AI assistant
IMAX CORP — Director's Dealing 2017
Mar 9, 2017
31800_dirs_2017-03-09_3d7357af-64f5-4ca8-82dd-586192684d3d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMAX CORP (IMAX)
CIK: 0000921582
Period of Report: 2017-03-07
Reporting Person: McClymont Patrick (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-03-07 | restricted share units | $ | A | 31202 | Acquired | 2020-12-01 | common shares (31202) | Direct |
| 2017-03-07 | stock options (to buy) | $32.45 | A | 37836 | Acquired | 2024-03-07 | common shares (37836) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| common shares (opening balance) | 0 | Direct |
Footnotes
F1: Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation.
F2: Each restricted share unit is the economic equivalent of one common share of IMAX Corporation.
F3: The restricted share units vest and will be converted to common shares in four installments: 6,240 on March 7, 2018; 7,801 on each of March 7, 2019 and March 7, 2020 and 9,360 on December 1, 2020.
F4: The stock options become exercisable in four installments: 7,567 on March 7, 2018, 9,459 on each of March 7, 2019 and March 7, 2020 and 11,351 on March 7, 2021.
F5: This represents the number of shares for this transaction only. Mr. McClymont's aggregate remaining outstanding option and restricted share unit balances following this transaction will be 53,559 and 42,917 respectively.